About
My lab use a variety of ‘omic, imaging, biochemistry, cell signalling and phenotypic assays to investigate isoform and mutation-specific Ras signalling and drug resistance. Our quantitative/systems-focussed approaches are aimed at understanding how cellular context determines the outputs of intracellular cancer signalling networks so that we can inform novel anti-cancer therapeutic strategies
Prizes or Honours
- NWCR Chair in Molecular Oncology (NWCR, 2015)
Funded Fellowships
- Royal Society URF renewal (Royal Society, 2009)
- Royal Society University Research Fellowship (Royal Society, 2003)